Replasyn, Sodium hyaluronate MW 500-730 kDa

Replasyn, Sodium hyaluronate MW 500-730 kDa

Products
Replasyn, Sodium hyaluronate MW 500-730 kDa
Replasyn, Sodium hyaluronate MW 500-730 kDa

Information

Temporary synovial fluid supplementation in traumatic and degenerative joint disorders such as osteoarthritis effecting ankle, trapeziometacarpal joint, temporomandibular joint, knee, hip and shoulder. The product is indicated in the treatment of persistent pain after initial failure of analgesics or in case of failure or intolerance to non-steroidal antiinflammatory drugs.
Main Categories
Finished Dosage Forms
All Categories
Finished Dosage FormsInjectables
Supplied from
Italy
Fidia Farmaceutici SpaFidia Farmaceutici Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, wound healing, ophthalmology, aesthetic and autologous biological therapy. Over 55 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of MW (over 700 patents). Manufacturing operations - located in Italy - are inspected and approved by major international health authorities, including the US and Korean FDA, the Brazi...

Log in

See all the content and easy-to-use features by logging in or registering!